Detalhe da pesquisa
1.
Clinical factors associated with patterns of endocrine therapy adherence in premenopausal breast cancer patients.
Breast Cancer Res
; 26(1): 59, 2024 Apr 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38589932
2.
Incidence and survival of primary metastatic breast cancer in Denmark; implication of breast cancer screening, classification, and staging practice.
Acta Oncol
; 63: 277-287, 2024 May 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38711384
3.
High inter-laboratory variability in the assessment of HER2-low breast cancer: a national registry study on 50,714 Danish patients.
Breast Cancer Res
; 25(1): 139, 2023 11 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37946261
4.
Treating brain metastases in metastatic breast cancer: outcomes after stereotactic radiosurgery examined in a retrospective, single-center cohort analysis.
Acta Oncol
; 62(11): 1502-1510, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37750329
5.
Use of beta-blockers and risk of contralateral breast cancer.
Int J Cancer
; 150(10): 1619-1626, 2022 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34985760
6.
A catalog of curated breast cancer genes.
Breast Cancer Res Treat
; 191(2): 431-441, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34755241
7.
Single-nucleotide polymorphisms and the effectiveness of taxane-based chemotherapy in premenopausal breast cancer: a population-based cohort study in Denmark.
Breast Cancer Res Treat
; 194(2): 353-363, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35501422
8.
Clinical behavior of recurrent hormone receptor-positive breast cancer by adjuvant endocrine therapy within the Breast International Group 1-98 clinical trial.
Cancer
; 127(5): 700-708, 2021 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33290610
9.
Tumour-infiltrating CD4-, CD8- and FOXP3-positive immune cells as predictive markers of mortality in BRCA1- and BRCA2-associated breast cancer.
Br J Cancer
; 125(10): 1388-1398, 2021 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-34365471
10.
Cumulative incidence of cardiovascular events under tamoxifen and letrozole alone and in sequence: a report from the BIG 1-98 trial.
Breast Cancer Res Treat
; 185(3): 697-707, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33159633
11.
Socioeconomic position and prognosis in premenopausal breast cancer: a population-based cohort study in Denmark.
BMC Med
; 19(1): 235, 2021 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-34587961
12.
Tumour-infiltrating lymphocytes and response to neoadjuvant letrozole in patients with early oestrogen receptor-positive breast cancer: analysis from a nationwide phase II DBCG trial.
Breast Cancer Res
; 22(1): 46, 2020 05 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-32410705
13.
The role of H1 antihistamines in contralateral breast cancer: a Danish nationwide cohort study.
Br J Cancer
; 122(7): 1102-1108, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32063603
14.
Breast cancer survival in Nordic BRCA2 mutation carriers-unconventional association with oestrogen receptor status.
Br J Cancer
; 123(11): 1608-1615, 2020 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32939053
15.
Induction of PIK3CA alterations during neoadjuvant letrozole may improve outcome in postmenopausal breast cancer patients.
Breast Cancer Res Treat
; 184(1): 123-133, 2020 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-32748297
16.
Predictive pharmacogenetic biomarkers for breast cancer recurrence prevention by simvastatin.
Acta Oncol
; 59(9): 1009-1015, 2020 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-32351149
17.
Leukocyte nadir as a predictive factor for efficacy of adjuvant chemotherapy in breast cancer. Results from the prospective trial SBG 2000-1.
Acta Oncol
; 59(7): 825-832, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32347139
18.
PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial.
Breast Cancer Res
; 21(1): 39, 2019 03 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30867034
19.
Nonaspirin NSAIDs and contralateral breast cancer risk.
Int J Cancer
; 144(6): 1243-1250, 2019 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30362513
20.
Basal biomarkers nestin and INPP4B predict gemcitabine benefit in metastatic breast cancer: Samples from the phase III SBG0102 clinical trial.
Int J Cancer
; 144(10): 2578-2586, 2019 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30411790